William Mulholland’s Post

Register for our webinar: http://spr.ly/6045qX8VT The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

Register for our webinar: http://spr.ly/6045qX8VT The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

Register for our webinar: https://lnkd.in/e3RJbR6f The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

The LATAM pharmaceutical market is on the rise, valued at $98 billion and poised for a remarkable 10.1% growth— underscoring the region’s potential as a hub for innovation, local manufacturing, and biotechnology. However, challenges such as technology gaps and supply chain constraints remain. From Data to Artificial Intelligence: How is Latin America Growing? Join our upcoming Summit LATAM hosted by Clarivate in partnership with ABIQUIFI, on Oct 7 in Milan to foster dialogue among key stakeholders in the health sector, from private entities to regulatory agencies. Don't miss this chance to be part of a transformative conversation. Register | Portuguese: https://lnkd.in/eiz59Kqc Register | Spanish: https://lnkd.in/epj6ebqJ #ArtificialIntelligence #LATAM #Innovation #Pharmaceuticals #LATAMSummit #Regulatory #DataInnovation

The LATAM pharmaceutical market is on the rise, valued at $98 billion and poised for a remarkable 10.1% growth— underscoring the region’s potential as a hub for innovation, local manufacturing, and biotechnology. However, challenges such as technology gaps and supply chain constraints remain. From Data to Artificial Intelligence: How is Latin America Growing? Join our upcoming Summit LATAM hosted by Clarivate in partnership with ABIQUIFI, on Oct 7 in Milan to foster dialogue among key stakeholders in the health sector, from private entities to regulatory agencies. Don't miss this chance to be part of a transformative conversation. Register | Portuguese: https://lnkd.in/eiz59Kqc Register | Spanish: https://lnkd.in/epj6ebqJ #ArtificialIntelligence #LATAM #Innovation #Pharmaceuticals #LATAMSummit #Regulatory #DataInnovation

#Canada’s #Government plays a pivotal role in drug development, funding nearly 20% of all #pharmaceutical R&D nationwide. Despite this, only 15% of new drugs developed in Canada reach global markets. This disparity highlights the challenges Canadian #companies face in scaling innovations. Greater #privateequity investment and streamlined approval processes could unlock untapped potential, but questions remain about whether the current system encourages long-term growth. Discover how private equity can drive innovation: https://lnkd.in/eK5Z7u_m.

Networking is not just about connecting people. It's about connecting people with ideas, opportunities, and aspirations to create a collaborative future. It was an invaluable opportunity to engage in discussions with Secretary General of the China Association of Pharmaceutical Equipment. The dialogue opened doors for exchanging ideas, emphasizing mutual interests, and opportunities. Discussions revolved around the latest technological advancements, regulatory standards, and emerging trends. The exchange of ideas highlighted the importance of innovation and quality in improving healthcare outcomes. Establishing these connections marks a promising step towards an innovative future. #pharmaceutical #healthcare #globalnetworking

In 2023, global pharmaceutical R&D spending soared past $300 billion - more than double the $137 billion spent in 2012. This investment covers every phase, from disease research and compound testing to regulatory approval. Unlike many industries, pharma faces unique pressures to innovate, driven by time-limited patents and the looming competition from generics. As a result, pharma companies increasingly focus on specialty drugs and high R&D intensity to stay competitive. New trends like outsourcing R&D and integrating big data for predictive modeling are reshaping the landscape, making tech partnerships vital to developing safer, more efficient drugs. #PharmaR&D #Innovation #Healthcare #Data Source - https://lnkd.in/eJvz93Rh

The Draghi Report provides an in-depth analysis of the pharmaceutical sector in the EU, highlighting the strategic role pharma plays in driving innovation and boosting the European economy’s competitiveness. Key challenges identified in the report include the need to enhance R&D capacity, support SMEs, reduce regulatory fragmentation, and integrate artificial intelligence to improve research and market access.   Stay tuned for insights into how the Draghi Report proposes innovative solutions to strengthen the competitiveness of the pharma sector and promote supply chain resilience across the EU. #EUPublicAffairs #DraghiReport #Pharma #Competitiveness #LykkeAdvice

The four new Fact to the Future reports are available now. Congrats to the team to edition 2! 🍾 Check out the #FttF Life Sciences industry report: